Simplex Trading
AXSM icon

Simplex Trading’s Axsome Therapeutics AXSM Stock Holding History

Simplex Trading’s Portfolio AXSM Stock Details AXSM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$10.2M Buy
41,500
+37,700
+992% +$8.18M 0.01% 752
2026
Q1 		$642K Sell
3,800
-20,900
-85% -$3.61M ﹤0.01% 2978
2025
Q4 		$4.51M Buy
24,700
+2,600
+12% +$363K ﹤0.01% 1353
2025
Q3 		$2.68M Sell
22,100
-15,500
-41% -$1.75M ﹤0.01% 2023
2025
Q2 		$3.92M Buy
37,600
+16,500
+78% +$1.75M ﹤0.01% 1551
2025
Q1 		$2.46M Sell
21,100
-109,400
-84% -$12.5M ﹤0.01% 1854
2024
Q4 		$11M Buy
130,500
+31,400
+32% +$2.89M 0.01% 963
2024
Q3 		$8.91M Buy
99,100
+72,700
+275% +$6.35M 0.01% 1107
2024
Q2 		$2.13M Sell
26,400
-2,200
-8% -$163K ﹤0.01% 2143
2024
Q1 		$2.28M Buy
28,600
+11,300
+65% +$948K ﹤0.01% 2272
2023
Q4 		$1.38M Buy
17,300
+4,600
+36% +$308K ﹤0.01% 2706
2023
Q3 		$887K Sell
12,700
-39,100
-75% -$2.92M ﹤0.01% 2794
2023
Q2 		$3.72M Sell
51,800
-21,300
-29% -$1.57M ﹤0.01% 1516
2023
Q1 		$4.51M Sell
73,100
-24,000
-25% -$1.58M ﹤0.01% 1365
2022
Q4 		$7.49M Sell
97,100
-16,700
-15% -$998K 0.01% 991
2022
Q3 		$5.08M Sell
113,800
-93,900
-45% -$4.69M 0.01% 1198
2022
Q2 		$7.95M Buy
207,700
+148,200
+249% +$4.69M 0.01% 900
2022
Q1 		$2.46M Buy
59,500
+41,800
+236% +$1.3M ﹤0.01% 1891
2021
Q4 		$668K Buy
17,700
+16,200
+1,080% +$596K ﹤0.01% 3423
2021
Q3 		$102K Hold
1,500
– – ﹤0.01% 6592
2021
Q2 		$101K Buy
1,500
+1,470
+4,900% +$88.2K ﹤0.01% 6712
2021
Q1 		$169K Buy
+30
New +$2.11K ﹤0.01% 5005
2020
Q2 		– Sell
-727
Closed -$4.28M – 7585
2020
Q1 		$4.28M Sell
727
-275
-27% -$22.4K 0.01% 780
2019
Q4 		$10.4M Buy
1,002
+628
+168% +$25.4K 0.02% 451
2019
Q3 		$756K Buy
374
+17
+5% +$437 ﹤0.01% 2219
2019
Q2 		$919K Sell
357
-703
-66% -$14.1K ﹤0.01% 1980
2019
Q1 		$1.51M Buy
1,060
+1,056
+26,400% +$9.8K ﹤0.01% 1625
2018
Q4 		$1K Buy
+4
New +$13 ﹤0.01% 6704

Other funds holding AXSM

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Simplex Trading's AXSM Position: Q2 2026 in Review

Simplex Trading opened a new position in Axsome Therapeutics (AXSM) in Q2 2026: 19,643 shares worth $4.81M. The stake represents ﹤0.01% of the portfolio and ranks #1239 among its holdings. This is a return to the name: Simplex Trading previously reported a position in AXSM as recently as Q4 2025.

Simplex Trading first reported a position in AXSM in Q3 2018 and has held it in 29 quarters since. 506 funds tracked by Wall St. Rank hold AXSM as of Q2 2026.

  • Simplex Trading held 19,643 shares of Axsome Therapeutics worth $4.81M as of Q2 2026.
  • Axsome Therapeutics was a new Simplex Trading position in Q2 2026.
  • Axsome Therapeutics made up ﹤0.01% of Simplex Trading's portfolio in Q2 2026, its #1239 holding.
  • Simplex Trading first reported a position in Axsome Therapeutics in Q3 2018 and has held it in 29 quarters since.
  • 506 funds tracked by Wall St. Rank held Axsome Therapeutics as of Q2 2026.

Based on Simplex Trading's 13F filing for Q2 2026, filed 12 Aug 2026.